ACADIA Pharmaceuticals joins Russell 1000 Index
ACADIA Pharmaceuticals, a biopharmaceutical company that is dedicated to creating and selling novel medicines to resolve the unmet medical needs of central nervous system disorders, recently joined the Russell 1000 Index. Read More »
Alerts Sign-up